Michael Schultz Email

Co-Founder and Chief Science Officer Viewpoint Molecular Targeting, DBA Perspective Therapeutics . Perspective Therapeutics

Current Roles

Employees:
149
Revenue:
$36.2M
About
We develop game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Perspective Therapeutics Address

null, null
United States
Perspective Therapeutics Email

Past Companies

Viewpoint Molecular Targeting, Inc.Chief Science Officer
University of IowaAssociate Professor